These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21576572)
1. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572 [TBL] [Abstract][Full Text] [Related]
2. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Chren MM; Linos E; Torres JS; Stuart SE; Parvataneni R; Boscardin WJ J Invest Dermatol; 2013 May; 133(5):1188-96. PubMed ID: 23190903 [TBL] [Abstract][Full Text] [Related]
3. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830 [TBL] [Abstract][Full Text] [Related]
4. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee. Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292 [TBL] [Abstract][Full Text] [Related]
5. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer. Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077 [No Abstract] [Full Text] [Related]
6. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Chren MM; Sahay AP; Sands LP; Maddock L; Lindquist K; Bertenthal D; Bacchetti P Med Care; 2004 Oct; 42(10):1019-26. PubMed ID: 15377935 [TBL] [Abstract][Full Text] [Related]
7. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer. Shelton ME; Adamson AS Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583 [TBL] [Abstract][Full Text] [Related]
8. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study. Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088 [TBL] [Abstract][Full Text] [Related]
9. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery. Zabielinski M; Leithauser L; Godsey T; Gloster HM Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725 [TBL] [Abstract][Full Text] [Related]
10. Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic. Clark FL; Sahay A; Bertenthal D; Maddock L; Lindquist K; Grekin R; Chren MM Arch Dermatol; 2008 Sep; 144(9):1148-52. PubMed ID: 18794460 [TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467 [TBL] [Abstract][Full Text] [Related]
12. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619 [TBL] [Abstract][Full Text] [Related]
13. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Wilson LS; Pregenzer M; Basu R; Bertenthal D; Torres J; Asgari M; Chren MM Dermatol Surg; 2012 Apr; 38(4):570-84. PubMed ID: 22145798 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC). Yeom SD; Lee SH; Ko HS; Chung KY; Shin J; Choi GS; Byun JW Int J Dermatol; 2017 Jun; 56(6):e136-e139. PubMed ID: 28247925 [No Abstract] [Full Text] [Related]
15. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice. Werlinger KD; Upton G; Moore AY Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494 [TBL] [Abstract][Full Text] [Related]
16. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. Stuart SE; Schoen P; Jin C; Parvataneni R; Arron S; Linos E; Boscardin WJ; Chren MM J Am Acad Dermatol; 2017 Jun; 76(6):1131-1138.e1. PubMed ID: 28365039 [TBL] [Abstract][Full Text] [Related]
17. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery. Schinstine M; Goldman GD J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121 [TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery: a cost analysis. Cook J; Zitelli JA J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885 [TBL] [Abstract][Full Text] [Related]
19. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors. Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206 [TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer. Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]